. 2018 Jul;188(7):1723–1733. doi: 10.1016/j.ajpath.2018.03.012

Table 1.

Clinicopathologic Features of Included Patients

Patient ID	Age, years	Sex	Family history of pancreatic cancer	Sample ID	Dissected PanIN lesion	Diagnosis	Stage^∗	Histologic differentiation
37T	74	F	None	TH12	HG-PanIN	PDAC	T3N0M0	G2
49T	66	M	None	TH13	LG-PanIN (PanIN-2)	PDAC	T3N1M0	G2
49T	66	M	None	TH14	HG-PanIN	PDAC	T3N1M0	G2
39T	56	M	None	TH15	HG-PanIN	PDAC	T1N2M0	G3
70T	75	F	None	TH16	HG-PanIN	PDAC	T2N0M0	G1
19T	74	M	None	TH17	HG-PanIN	PDAC	T3N2M0	G2
69T	61	M	None	TH18	HG-PanIN	PDAC	T2N1M0	G3
22T	63	F	None	TH19	HG-PanIN	PDAC	T3N2M0	G3
45T	58	F	None	TH20	LG-PanIN (PanIN-2)	Ampullary carcinoma	T3N0M0	G2
45T	58	F	None	TH21	HG-PanIN	Ampullary carcinoma	T3N0M0	G2
29T	63	F	None	TH22	HG-PanIN	Extensive PanIN	TisN0M0	N/A
78T	54	F	None	TH23	HG-PanIN	PDAC	T2N0M0	G3
780T	70	F	None	TH24	HG-PanIN	PDAC	T3N1M0	G2

F, female; M, male; HG, high-grade; LG, low-grade; PanIN, pancreatic intraepithelial neoplasia.

^∗

Pathologic diagnosis determined by AJCC Cancer Staging Manual, eighth edition²⁸ (pancreatic ductal adenocarcinoma, PDAC) and AJCC Cancer Staging Manual, seventh edition²⁹ (ampullary carcinoma).